300813 Stock Overview
Offers life science system solutions in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Zhejiang Tailin BioEngineering Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥18.70 |
| 52 Week High | CN¥29.90 |
| 52 Week Low | CN¥13.70 |
| Beta | 1.19 |
| 1 Month Change | 7.72% |
| 3 Month Change | -19.88% |
| 1 Year Change | 33.95% |
| 3 Year Change | -44.32% |
| 5 Year Change | -39.81% |
| Change since IPO | 47.22% |
Recent News & Updates
Recent updates
What Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 43% Share Price Gain Is Not Telling You
Oct 08
Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) 42% Share Price Surge Not Quite Adding Up
May 09Zhejiang Tailin BioEngineeringLtd's (SZSE:300813) Sluggish Earnings Might Be Just The Beginning Of Its Problems
May 01Zhejiang Tailin BioEngineering Co.,Ltd's (SZSE:300813) Shares Climb 32% But Its Business Is Yet to Catch Up
Mar 08Shareholder Returns
| 300813 | CN Life Sciences | CN Market | |
|---|---|---|---|
| 7D | 6.2% | 7.6% | 3.3% |
| 1Y | 34.0% | 7.6% | 19.0% |
Return vs Industry: 300813 exceeded the CN Life Sciences industry which returned 5.3% over the past year.
Return vs Market: 300813 exceeded the CN Market which returned 17.4% over the past year.
Price Volatility
| 300813 volatility | |
|---|---|
| 300813 Average Weekly Movement | 5.5% |
| Life Sciences Industry Average Movement | 5.9% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in CN Market | 10.6% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 300813 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 300813's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 888 | Da Lin Ye | www.tailingood.com |
Zhejiang Tailin BioEngineering Co.,Ltd offers life science system solutions in China. The company offers cell and gene therapy solutions, including biosafety ferret isolators, sterile pig preparation solutions, aseptic filling workstation, cell preparation workstation, and robotic packaging workstations; drug development and sterile production solutions, comprising sterile packaging, highly active drug development/production, aseptic material transfer, packaging and test equipment, automated production solutions, sterility tests, and sterile connectors; microbiological detection systems; sterility testing systems; biodecontamination and infection control solutions; analytical instruments; quality control solutions, and laboratory animals/scientific research products, as well as active microbial products, and membrane materials. Its products are used in bio-pharmaceuticals, biosafety, disease control, food safety, and other industries.
Zhejiang Tailin BioEngineering Co.,Ltd Fundamentals Summary
| 300813 fundamental statistics | |
|---|---|
| Market cap | CN¥2.27b |
| Earnings (TTM) | CN¥9.67m |
| Revenue (TTM) | CN¥309.21m |
234.3x
P/E Ratio7.3x
P/S RatioIs 300813 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300813 income statement (TTM) | |
|---|---|
| Revenue | CN¥309.21m |
| Cost of Revenue | CN¥169.83m |
| Gross Profit | CN¥139.37m |
| Other Expenses | CN¥129.70m |
| Earnings | CN¥9.67m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 28, 2025
| Earnings per share (EPS) | 0.08 |
| Gross Margin | 45.07% |
| Net Profit Margin | 3.13% |
| Debt/Equity Ratio | 27.0% |
How did 300813 perform over the long term?
See historical performance and comparisonDividends
0.5%
Current Dividend Yield118%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 15:33 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zhejiang Tailin BioEngineering Co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.